Can Nasal Positive Airway Pressure (NPAP) devices be used in patients with head trauma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Nasopharyngeal airways (NPAs) should be used with caution in head trauma patients, as they are generally acceptable when an oropharyngeal airway is difficult to place or not tolerated, but contraindicated in patients with suspected basilar skull fractures or significant facial trauma. The primary concern with using NPAs in head trauma patients is the risk of inadvertent intracranial placement through a fractured cribriform plate, which could lead to serious complications including cerebrospinal fluid leakage or direct brain injury 1. When using an NPA in appropriate head trauma cases, it is essential to ensure proper sizing, typically based on the distance from the nostril to the tragus of the ear, lubricate adequately with water-soluble lubricant, and insert gently along the floor of the nasal cavity. Some key considerations for airway management in head trauma patients include:

  • Indications for tracheal intubation, such as a Glasgow Coma Scale (GCS) score of 8 or less, significantly deteriorating conscious level, loss of protective laryngeal reflexes, and hypercarbia 1
  • The importance of controlling ventilation and monitoring end-tidal CO2 levels in intubated patients to maintain optimal cerebral perfusion pressure 1
  • The potential benefits and limitations of using transcranial Doppler to assess the severity of traumatic brain injury 1 It is crucial to weigh the potential benefits of using an NPA against the risks and to be prepared to remove the NPA and consider alternative airway management if complications arise. Always monitor for bleeding after insertion, which can occur due to the vascularity of the nasal mucosa. In general, the use of NPAs in head trauma patients requires careful consideration of the individual patient's condition and the potential risks and benefits of this intervention.

From the Research

Use of NPAs in Head Trauma

  • The use of non-pharmacological agents (NPAs) in head trauma is not directly addressed in the provided studies, but some studies discuss the use of non-opioid analgesics and multimodal pain management in trauma patients 2, 3.
  • A study on acute pain relief in children with musculoskeletal trauma found that ibuprofen provided the best analgesia among the three study medications, including acetaminophen and codeine 4.
  • Another study reviewed the properties of various non-opioid analgesics, including acetaminophen, nonsteroidal anti-inflammatory drugs, α2 agonists, N-methyl-d-aspartate (NMDA) receptor antagonists, skeletal muscle relaxants, sodium channel blockers, and local anesthetics, and encouraged pharmacists to play an active role in the selection, initiation, and dose-titration of multimodal analgesia 3.
  • A systematic review on the effect of opioids on cerebral physiology in traumatic brain injury found that opioids can have either no effect or an increase in intracranial pressure (ICP) with associated decreases in cerebral perfusion pressure (CPP) and mean arterial pressure (MAP) 5.

Non-Opioid Analgesics in Head Trauma

  • Non-opioid analgesics, such as acetaminophen and nonsteroidal anti-inflammatory drugs, can be used as adjuncts or alternatives to opioids in trauma patients 2, 3.
  • Ketamine, a non-opioid analgesic, has been shown to have a protective effect against ischemic and traumatic brain damage in animal studies, but its use in head trauma patients is still being studied 6.
  • The choice of non-opioid agents should be based on patient comorbidities, hemodynamic stability, and the agents' respective adverse effect profiles 3.

Multimodal Pain Management in Head Trauma

  • Multimodal pain management, which involves the use of multiple non-pharmacological and pharmacological interventions, can be effective in reducing pain and opioid use in trauma patients 2, 3.
  • A multidisciplinary plan for management of pain should be formulated during transitions of care, and pharmacists can play a key role in the selection, initiation, and dose-titration of analgesic agents based on patient-specific factors 3.

References

Related Questions

What is the recommended dosage administration for acetaminophen with codeine?
What are the new studies on the administration of ketamine (Ketamine) in patients with suspected or confirmed head injury and those with hypertensive emergency?
Is domperidone (antiemetic medication) safe to use in patients with traumatic brain injury?
What is the recommended dose of Panadol (acetaminophen) and ibuprofen for a 3-year-old girl weighing 14.3 kg with an ulnar fracture?
Are controlled analgesics, such as opioids, contraindicated in patients with Traumatic Brain Injury (TBI) and intracranial hemorrhage?
What is the diagnosis for the colon polyps found in the ileocecal valve, ascending colon, transverse colon, and descending colon, which were removed using hot biopsy forceps (HBF) and diagnosed as tubular adenomas?
What is the appropriate management for multiple colon polyps, including tubular adenomas, found in the ileocecal valve, ascending colon, transverse colon, and descending colon, diagnosed via hot biopsy forceps (HBFP)?
What are the implications of mild Left Pulmonary Artery (LPA) hypoplasia/stenosis and mild aortic arch hypoplasia?
What is the diagnosis for a patient with leukopenia (White Blood Cell count 4.2 K/uL), anemia (Red Blood Cell count 4.02 M/uL, hemoglobin 11.6 g/dL), and thrombocytopenia is not present (platelets 350 K/uL)?
When to hold amlodipine (calcium channel blocker)?
What is the significance of mild Left Pulmonary Artery (LPA) hypoplasia/stenosis and mild aortic arch hypoplasia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.